How many institutions held VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in Q2 2021?

53 institutional investors reported VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value for Q2 2021. Use the holders table for investor-level position and value details.

Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)

Q: What does CUSIP 92511W108 represent in this 13F holders report?

CUSIP 92511W108 is the security identifier for VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

CUSIP: 92511W108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 92,448,158
Total 13F shares: 9,937,044
Share change: +10,656
Total reported value: $112,291,153
Price per share: $11.30
Number of holders: 53
Value change: -$1,689,115
Number of buys: 22
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 92511W108?
CUSIP 92511W108 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 92511W108:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	3.9%	3,610,412	$54,698,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	1.6%	1,479,733	$22,418,000	—	31 Mar 2021	13F
KORNITZER CAPITAL MANAGEMENT INC /KS	13F	Company	0.78%	719,836	$10,906,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	0.77%	710,683	$10,766,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.76%	701,230	$10,624,000	—	31 Mar 2021	13F
Altium Capital Management LLC	13F	Company	0.61%	562,954	$8,529,000	—	31 Mar 2021	13F
Fosun International Ltd	13F	Company	0.31%	282,408	$4,279,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.26%	236,949	$3,590,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.24%	218,350	$3,308,000	—	31 Mar 2021	13F
Monashee Investment Management LLC	13F	Company	0.22%	200,000	$3,030,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	199,158	$3,017,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.16%	151,915	$2,302,000	—	31 Mar 2021	13F
SteelPeak Wealth, LLC	13F	Company	0.14%	132,961	$2,014,000	—	31 Mar 2021	13F
Jefferies Group LLC	13F	Company	0.12%	112,000	$1,696,800	—	31 Mar 2021	13F
David M. Knott	13F	Individual	0.08%	78,424	$1,188,000	—	31 Mar 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.05%	44,313	$672,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.05%	44,054	$667,000	—	31 Mar 2021	13F
Parian Global Management LP	13F	Company	0.04%	39,560	$599,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	33,418	$506,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.04%	32,788	$497,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	31,117	$472,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	27,741	$421,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.03%	25,200	$382,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	21,920	$332,000	—	31 Mar 2021	13F
MML INVESTORS SERVICES, LLC	13F	Company	0.02%	21,075	$319,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	18,758	$284,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	17,700	$268,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.02%	17,300	$262,000	—	31 Mar 2021	13F
Capital Investment Advisory Services, LLC	13F	Company	0.02%	15,125	$229,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	13,434	$204,000	—	31 Mar 2021	13F
Pinz Capital Management, LP	13F	Company	0.01%	13,422	$203,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.01%	13,100	$198,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	12,800	$194,000	—	31 Mar 2021	13F
BARCLAYS PLC	13F	Company	0.01%	10,399	$157,000	—	31 Mar 2021	13F
Virtu Financial LLC	13F	Company	0.01%	10,200	$155,000	—	31 Mar 2021	13F
BECK MACK & OLIVER LLC	13F	Company	0.01%	10,000	$152,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.01%	9,921	$150,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	8,310	$126,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	8,107	$123,000	—	31 Mar 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	7,250	$110,000	—	31 Mar 2021	13F
A. Brian Davis	3/4/5	Chief Financial Officer	— class O/S missing	12,900	$83,721	—	04 Jun 2021	3/4/5
MORGAN STANLEY	13F	Company	0.01%	4,623	$70,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	4,273	$65,000	—	31 Mar 2021	13F
Spire Wealth Management	13F	Company	0%	3,528	$53,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	3,285	$50,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	2,081	$31,000	—	31 Mar 2021	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,770	$26,816	—	31 Mar 2021	13F
Legal & General Group Plc	13F	Company	0%	1,437	$22,000	—	31 Mar 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	1,080	$16,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0%	824	$12,000	—	31 Mar 2021	13F

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2021

As of 30 Jun 2021, Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,937,044 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, BlackRock Inc., VANGUARD GROUP INC, Altium Capital Management LP, MILLENNIUM MANAGEMENT LLC, Fosun International Ltd, FMR LLC, and STATE STREET CORP. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.